DEC 22, 2015 10:47 AM PST

Ketamine May Help With Depression Linked to Overeating

WRITTEN BY: Julianne Chiaet
Depression is a mood disorder in which a person constantly feels very sad, hopeless, and unimportant

Processed foods rich in saturated fat have become a major part of the American diet. Two-thirds of American adults are overweight or obese. 

Type 2 diabetes is one of the over 60 chronic diseases linked to obesity. Diets rich in fat also impair cognitive functions, shrinks the hippocampus, and increase one’s risk of developing depression. 

People with type 2 diabetes are 54 percent more likely to develop depression than those without type 2 diabetes, according to a 2008 study in the Journal of the American Medical Association. Diabetes is a risk factor for depression. More surprisingly, depression is a risk factor for diabetes. 

Processed foods rich in saturated fat have become a major part of the American diet. Researchers at Yale wanted to examine the impact of a high-fat diet on the biological processes that contribute to the development of type-2 diabetes, depression, and anxiety. They put one group of rats on a high-fat diet by feeding the group six times the normal amount of fat.

The scientists found that, after four months on the high-fat diet, the rats exhibited signs of depression and anxiety, and their synaptic plasticity and metabolism were disrupted.

The scientists found that a single dose of ketamine, more popularly known as the illicit drug "Special K," reversed the symptoms quickly. Ketamine has been shown to reduce symptoms of chronic depression in bipolar and depressed patients who have not responded to other antidepressants. The drug works in just two hours. 

Depression and chronic stress damage synaptic connections in the brain. The effects of a high-fat diet overlap with the effects of chronic stress, said neurobiologist and senior study author Ronald Duman. These effects could be a contributing factor in depression and type 2 diabetes.

Ketamine targets a different part of the brain than traditional antidepressants. Instead of focusing on serotonin, norepinephrine or dopamine neurotransmitters, ketamine activates the mTORC pathway and focuses on a glutamate neurotransmitter.
 

Glutamate accounts for more than 90 percent of all synapses in the human brain. The single dose of ketamine was found to reverse the disruption of mTORC signaling pathways caused by the high-fat diet. 

The mTORC pathway is also involved in cellular responses to energy and metabolism.

Further studies need to be done to figure out the effects of ketamine on the metabolism. In addition, scientists must figure out how patients can use the drug without experiencing the dangerous side effects, such as addiction and severe bladder inflammation. Thus, they will have to find the proper dosage as an antidepressant. The use of Ketamine as an antidepressant is still a subject of clinical trials.

The study was published in the journal Neuropharmacology

Sources: press release via EurekAlert! and Yale University, study in Neuropharmacology, Diabetes Forecast, Scientific American
About the Author
  • Julianne (@JuliChiaet) covers health and medicine for LabRoots. Her work has been published in The Daily Beast, Scientific American, and MailOnline. While primarily a science journalist, she has also covered culture and Japanese organized crime. She is the New York Board Representative for the Asian American Journalists Association (AAJA). • To read more of her writing, or to send her a message, go to Jchiaet.com
You May Also Like
DEC 20, 2020
Microbiology
How Do mRNA Vaccines Work?
DEC 20, 2020
How Do mRNA Vaccines Work?
Scientist Katalin Karikó studied mRNA vaccines for years. She spent years getting grant rejections, but has now helped c ...
DEC 24, 2020
Microbiology
A New, Infectious Strain of SARS-CoV-2 Emerges
DEC 24, 2020
A New, Infectious Strain of SARS-CoV-2 Emerges
The UK recently reported that it had detected a new variant of the SARS-CoV-2 pandemic virus, which causes COVID-19. Thi ...
DEC 29, 2020
Microbiology
How CRISPR Can Help Create a Vaccine for a Common Parasite
DEC 29, 2020
How CRISPR Can Help Create a Vaccine for a Common Parasite
The parasite Toxoplasma gondii is thought to infect a third of the people on the planet as well as a wide range of other ...
DEC 30, 2020
Drug Discovery & Development
Llama Antibody Prevents Infection by COVID-19
DEC 30, 2020
Llama Antibody Prevents Infection by COVID-19
There's more to llamas than being livestock and hilarious companion animals. They also harbor an immune system capab ...
JAN 07, 2021
Cardiology
Climbing Some Stairs is a Good Way to Check Heart Health
JAN 07, 2021
Climbing Some Stairs is a Good Way to Check Heart Health
If you can climb four flights in under a minute, your heart is probably in good shape, according to new work presented a ...
JAN 18, 2021
Cell & Molecular Biology
MicroRNAs May be Treatment Targets for Traumatic Brain Injury
JAN 18, 2021
MicroRNAs May be Treatment Targets for Traumatic Brain Injury
Traumatic brain injury, which can happen after a blow to the head, has been called a silent epidemic and is the number o ...
Loading Comments...